These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

640 related items for PubMed ID: 23040680

  • 1. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
    Tascini C, Flammini S, Leonildi A, Ciullo I, Tagliaferri E, Menichetti F.
    J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
    [Abstract] [Full Text] [Related]

  • 2. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M, Hidalgo Orozco R, Rodríguez Garrido S, Gaona Álvarez C, Sánchez Silos RM, Hernández Rastrollo R, Martínez Tallo E, Cordero Carrasco JL.
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [Abstract] [Full Text] [Related]

  • 3. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Tarasi A, Cassone M, Monaco M, Tarasi D, Pompeo ME, Venditti M.
    J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
    [Abstract] [Full Text] [Related]

  • 4. A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy.
    Cojutti P, Scarparo C, Sartor A, Coato P, Rigoli R, Pea F.
    Diagn Microbiol Infect Dis; 2015 Jan; 81(1):53-6. PubMed ID: 25301716
    [Abstract] [Full Text] [Related]

  • 5. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D, Toshkova K, Gavrilova V.
    Vutr Boles; 2000 Jan; 32(2):35-40. PubMed ID: 11227664
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Presence of multiple van genes among glycopeptide non-susceptible Staphylococcus aureus exhibiting in vitro MIC creep phenomenon: A study from north-east India.
    Hazarika M, Nath K, Bhowmik D, Singha KM, Dhar D, Bhattacharjee A.
    Indian J Med Res; 2024 Jul; 160(1):109-117. PubMed ID: 39382498
    [Abstract] [Full Text] [Related]

  • 13. Glycopeptide minimum inhibitory concentration creep among meticillin-resistant Staphylococcus aureus from 2006-2011 in China.
    Zhuo C, Xu YC, Xiao SN, Zhang GY, Zhong NS.
    Int J Antimicrob Agents; 2013 Jun; 41(6):578-81. PubMed ID: 23562222
    [Abstract] [Full Text] [Related]

  • 14. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.
    Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew DP.
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3861-70. PubMed ID: 20547791
    [Abstract] [Full Text] [Related]

  • 15. Glycopeptide and daptomycin susceptibility trends among clinical isolates of methicillin-resistant Staphylococcus aureus in a tertiary care center in North India.
    Singh A, Prasad KN, Rai RP, Singh SK, Rahman M, Tripathi A, Srivastava JK.
    J Infect Public Health; 2015 Sep; 8(4):341-5. PubMed ID: 25797814
    [Abstract] [Full Text] [Related]

  • 16. Unmasking a looming crisis: Escalating MIC of last resort drugs against MRSA isolates from a tertiary care hospital in Central India.
    Bawankar NS, Agrawal GN, Zodpey Shrikhande SS.
    Indian J Med Microbiol; 2024 Sep; 51():100707. PubMed ID: 39173910
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].
    Çıkman A, Aydın M, Gülhan B, Parlak M, Gültepe B, Kalaycı Y, Bayındır Bilmen F, Solmaz S, Özekinci T.
    Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test].
    Pelitli TS, Cesur S, Kınıklı S, Irmak H, Demiröz AP, Karakoç E.
    Mikrobiyol Bul; 2011 Oct; 45(4):758-61. PubMed ID: 22090309
    [Abstract] [Full Text] [Related]

  • 20. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.
    Trakulsomboon S, Danchaivijitr S, Rongrungruang Y, Dhiraputra C, Susaemgrat W, Ito T, Hiramatsu K.
    J Clin Microbiol; 2001 Feb; 39(2):591-5. PubMed ID: 11158112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.